Butterfly Network has launched its third-generation handheld point-of-care ultrasound (POCUS) system, Butterfly iQ3, which in January received clearance from the U.S. Food and Drug Administration (FDA).
Butterfly iQ3 is powered by a semiconductor chip with a data transfer rate that is double that of its predecessor, the company said. It also features a novel “no focus” rubber lens, allowing providers to identify anatomy, observe small structures, and make more confident diagnostic decisions.
Launching on Butterfly iQ3 are two new 3D imaging capabilities designed to make image capturing easier: iQ Slice and iQ Fan. These tools join Butterfly’s existing feature list of over 20 anatomical presets, six imaging modes, and a collection of AI and advanced imaging tools.
Additionally, Butterfly iQ3 features an ergonomic design that is smaller and lighter and has a stronger battery. This includes a 17% smaller probe face for better access to cardiac and lung imaging, a 7% shorter probe with ergonomic weight distribution to reduce physical strain on scanners and give users better control, three configurable control buttons, and a 2.5 times faster charge time than Butterfly iQ+ along with up to two hours of thermal run time.
